Dr. Alex Brewer, SCHOOL PSYCHOLOGIST Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 925 N Meridian St Ste 100, Sunman, IN 47041 Phone: 812-623-2212 |
News Archive
Researchers have identified a drug that targets the first step in the toxic chain reaction leading to the death of brain cells, suggesting that treatments could be developed to protect against Alzheimer's disease, in a similar way to how statins are able to reduce the risk of developing heart disease.
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
Cymetrix Board Member Joe Sullivan was recognized by the Forum for Corporate Directors as a 2010 Director of the Year Honoree. He was recognized in the category of Corporate Growth and Development for playing a significant role in enhancing the growth and operations of the companies he serves.
Researchers have found an association between inflammation from knee injuries and a progressive loss of joint lubrication, which may predispose people to arthritis. They have also found a way to quantify how much lubrication is lost following injury.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced third-quarter 2009 revenue of $540.8 million, down 6 percent or 4 percent constant dollar, compared with $573.7 million in the year-earlier period. Net loss for the 2009 third quarter was $9.3 million and diluted earnings per share was $(0.05) compared with net income of $75.9 million and EPS of $0.41 in the third quarter of 2008.
› Verified 4 days ago